Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastroenterology | 2 | 2021 | 190 | 1.200 |
Why?
|
| Endoscopic Mucosal Resection | 3 | 2024 | 72 | 1.180 |
Why?
|
| Endosonography | 2 | 2022 | 82 | 0.920 |
Why?
|
| Pancreatic Diseases | 1 | 2022 | 38 | 0.820 |
Why?
|
| Pancreatitis, Chronic | 1 | 2022 | 68 | 0.790 |
Why?
|
| Colonoscopy | 2 | 2021 | 239 | 0.760 |
Why?
|
| Sutures | 1 | 2021 | 67 | 0.750 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2021 | 54 | 0.740 |
Why?
|
| Suture Techniques | 1 | 2021 | 199 | 0.710 |
Why?
|
| Cholestasis | 1 | 2021 | 161 | 0.680 |
Why?
|
| Mental Health | 1 | 2021 | 342 | 0.610 |
Why?
|
| Liver Diseases | 1 | 2021 | 384 | 0.580 |
Why?
|
| Health Personnel | 1 | 2021 | 500 | 0.540 |
Why?
|
| Pandemics | 2 | 2021 | 1102 | 0.520 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 360 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 378 | 0.470 |
Why?
|
| Telemedicine | 1 | 2020 | 422 | 0.460 |
Why?
|
| Pancreas | 2 | 2022 | 214 | 0.340 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2024 | 78 | 0.270 |
Why?
|
| Neoplasm, Residual | 1 | 2024 | 122 | 0.220 |
Why?
|
| Fundoplication | 1 | 2024 | 66 | 0.220 |
Why?
|
| Colonic Polyps | 1 | 2024 | 78 | 0.210 |
Why?
|
| Rectum | 1 | 2023 | 97 | 0.210 |
Why?
|
| Humans | 17 | 2024 | 122293 | 0.200 |
Why?
|
| Feasibility Studies | 1 | 2024 | 749 | 0.190 |
Why?
|
| Bile Ducts | 1 | 2021 | 64 | 0.190 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2021 | 80 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2024 | 289 | 0.180 |
Why?
|
| Videoconferencing | 1 | 2020 | 21 | 0.180 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2020 | 31 | 0.180 |
Why?
|
| Workload | 1 | 2021 | 146 | 0.170 |
Why?
|
| Telephone | 1 | 2020 | 109 | 0.170 |
Why?
|
| Office Visits | 1 | 2020 | 75 | 0.170 |
Why?
|
| Endoscopy | 1 | 2021 | 282 | 0.170 |
Why?
|
| Neurosurgical Procedures | 1 | 2021 | 296 | 0.160 |
Why?
|
| United States | 4 | 2024 | 10487 | 0.160 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2018 | 13 | 0.160 |
Why?
|
| Cathartics | 1 | 2018 | 26 | 0.160 |
Why?
|
| Treatment Outcome | 6 | 2024 | 12044 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2024 | 5963 | 0.160 |
Why?
|
| Colon | 1 | 2021 | 348 | 0.150 |
Why?
|
| Retrospective Studies | 4 | 2024 | 15853 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 268 | 0.140 |
Why?
|
| Mallory-Weiss Syndrome | 1 | 2016 | 3 | 0.140 |
Why?
|
| Pancreatitis | 1 | 2018 | 130 | 0.140 |
Why?
|
| Hernia, Hiatal | 1 | 2016 | 54 | 0.140 |
Why?
|
| Intestine, Small | 1 | 2019 | 313 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 289 | 0.140 |
Why?
|
| Bacterial Infections | 1 | 2019 | 304 | 0.130 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 248 | 0.130 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 507 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 635 | 0.120 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2014 | 43 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2016 | 220 | 0.120 |
Why?
|
| Middle Aged | 6 | 2024 | 25639 | 0.120 |
Why?
|
| Quality of Life | 1 | 2024 | 1913 | 0.120 |
Why?
|
| IgA Deficiency | 1 | 2014 | 6 | 0.110 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2014 | 26 | 0.110 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2014 | 141 | 0.110 |
Why?
|
| Histocompatibility Testing | 1 | 2014 | 147 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 5013 | 0.110 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2014 | 201 | 0.100 |
Why?
|
| Adult | 5 | 2024 | 28732 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 3626 | 0.090 |
Why?
|
| Aged | 5 | 2024 | 18784 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 2385 | 0.070 |
Why?
|
| Male | 8 | 2024 | 59520 | 0.060 |
Why?
|
| Intestinal Polyps | 1 | 2024 | 29 | 0.060 |
Why?
|
| Female | 8 | 2024 | 64882 | 0.060 |
Why?
|
| Myotomy | 1 | 2024 | 18 | 0.060 |
Why?
|
| Margins of Excision | 1 | 2024 | 51 | 0.060 |
Why?
|
| Operative Time | 1 | 2024 | 158 | 0.060 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2024 | 66 | 0.050 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2024 | 69 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2024 | 240 | 0.050 |
Why?
|
| Equipment Design | 1 | 2024 | 596 | 0.050 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 253 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 6290 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 355 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1362 | 0.040 |
Why?
|
| Methane | 1 | 2019 | 12 | 0.040 |
Why?
|
| Hydrogen | 1 | 2019 | 38 | 0.040 |
Why?
|
| Breath Tests | 1 | 2019 | 179 | 0.040 |
Why?
|
| Necrosis | 1 | 2018 | 212 | 0.040 |
Why?
|
| Risk Factors | 2 | 2024 | 9902 | 0.040 |
Why?
|
| Steroids | 1 | 2018 | 203 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 729 | 0.030 |
Why?
|
| Esophagogastric Junction | 1 | 2016 | 27 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2016 | 82 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2016 | 154 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1034 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 1407 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 812 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2024 | 2997 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1772 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1158 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 758 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3229 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3307 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 18940 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 8760 | 0.020 |
Why?
|
| Child | 2 | 2014 | 24063 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 13777 | 0.010 |
Why?
|